BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hemophilia Alliance - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://hemoalliance.org
X-WR-CALDESC:Events for Hemophilia Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240620T140000
DTEND;TZID=America/New_York:20240620T150000
DTSTAMP:20260405T150342
CREATED:20240609T180107Z
LAST-MODIFIED:20240609T180107Z
UID:65966-1718892000-1718895600@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts – Practice Considerations for ROCTAVIAN™ (valoctocogene roxaparvovec-rvox) from BioMarin
DESCRIPTION:Date: Thursday\, June 20\, 2024\nTime: 2:00pm – 3:00pm ET \n\n \nTitle: Practice Considerations for ROCTAVIAN™ (valoctocogene roxaparvovec-rvox)  \nObjectives:   \n\n\nReview coverage and typical prior authorization criteria for ROCTAVIAN\n\nReview considerations and pricing education available for single-case agreements\n\nHemophilia Alliance’s gene therapy support for Member Hemophilia Treatment Centers\n\nSpeakers: \n\n\nJosh Sammon\, PharmD\, Senior Director\, Market Access\, Hemophilia\n\nHemophilia Alliance Team
URL:https://hemoalliance.org/alliance-events/a-webinar-on-practice-considerations-for-roctavian-from-biomarin/
CATEGORIES:Members Only,Webinar
END:VEVENT
END:VCALENDAR